Boston Scientific

From DolceraWiki
Revision as of 04:41, 28 July 2011 by Shweta.mittal@dolcera.com (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

1. Boston Scientific Announces FDA Approval and U.S. Launch of PROMUS® 2.25 mm Everolimus-Eluting Coronary Stent System.

2 PROMUS Element(TM) Stent Demonstrates Exceptional Safety and Effectiveness in PLATINUM Small Vessel Study.

3.Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN® Device